Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(14%)
Results Posted
100%(1 trials)

Phase Distribution

Ph phase_2
2
29%
Ph not_applicable
2
29%
Ph phase_1
1
14%
Ph phase_4
2
29%

Phase Distribution

1

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
2(28.6%)
Phase 4Post-market surveillance
2(28.6%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(5)
Completed(1)
Other(1)

Detailed Status

Not yet recruiting3
Recruiting1
unknown1
Completed1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (14.3%)
Phase 22 (28.6%)
Phase 42 (28.6%)
N/A2 (28.6%)

Trials by Status

not_yet_recruiting343%
recruiting114%
unknown114%
completed114%
enrolling_by_invitation114%

Recent Activity

1 active trials
Showing 5 of 7
not_yet_recruitingphase_4

Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study

NCT07523867
not_yet_recruitingphase_2

A Randomised Controlled Trial to Establish Whether Dapagliflozin and Spironolactone in Patients With Severe Aortic Stenosis Undergoing Aortic Valve Replacement, Result in Better Left Ventricular Mass Regression, Myocardial Health and Patient Reported Outcomes Than Standard-of-care Therapy Alone.

NCT07539259
recruitingphase_2

Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)

NCT07304817
not_yet_recruitingphase_1

A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression

NCT07431216
enrolling_by_invitationnot_applicable

Spironolactone and XPB-1 Integrity in the TFIIH Complex

NCT07415811
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07523867Phase 4

Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study

Not Yet Recruiting
NCT07539259Phase 2

A Randomised Controlled Trial to Establish Whether Dapagliflozin and Spironolactone in Patients With Severe Aortic Stenosis Undergoing Aortic Valve Replacement, Result in Better Left Ventricular Mass Regression, Myocardial Health and Patient Reported Outcomes Than Standard-of-care Therapy Alone.

Not Yet Recruiting
NCT07304817Phase 2

Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)

Recruiting
NCT07431216Phase 1

A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression

Not Yet Recruiting
NCT07415811Not Applicable

Spironolactone and XPB-1 Integrity in the TFIIH Complex

Enrolling By Invitation
NCT00211081Not Applicable

Spironolactone in Patients With Single Ventricle Heart

Completed
NCT00277693Phase 4

Cardiovascular Protective Effect of Spironolactone in Hemodialysis

Unknown

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7